5:30 PM
 | 
Jul 28, 2010
 |  BC Extra  |  Financial News

ViroPharma beats Street

ViroPharma Inc. (NASDAQ:VPHM) reported 2Q10 diluted GAAP EPS of $0.34, beating by $0.02 the Street's estimate of $0.32 and up from $0.20...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >